Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Inventory Average of $7.1 million for Q2 2026, up 115.57% year-over-year from $3.3 million in Q2 2025, and up 18.25% quarter-over-quarter from $6.0 million in Q1 2026.
Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Inventory Average for 4 consecutive years, with $7.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory Average rose 115.57% year-over-year to $7.1 million; the TTM figure through Jun 2026 stood at $7.1 million (up 115.57% YoY), while the FY2025 annual figure was $4.4 million, up 97.6% from the prior year.
- Inventory Average rose to $7.1 million in Q2 2026 per PHAT's latest filing, from $6.0 million in the prior quarter.
- Across five years, Inventory Average topped out at $7.1 million in Q2 2026 and bottomed at $111000.0 in Q3 2023.
- Historically, Inventory Average has averaged $3.1 million across 4 years, with a median of $3.2 million in 2024.
- Annual changes were most pronounced in 2024 — Inventory Average surged 2281.98% — and 2025, when it soared 33.17%.
- Phathom Pharmaceuticals' Inventory Average stood at $659500.0 in 2023, then surged by 379.08% to $3.2 million in 2024, then soared by 44.47% to $4.6 million in 2025, then jumped by 55.78% to $7.1 million in 2026.
- Business Quant data shows PHAT's Inventory Average at $7.1 million in Q2 2026, $6.0 million in Q1 2026, and $4.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.11 Mn |
| Mar 31, 2026 | 6.01 Mn |
| Dec 31, 2025 | 4.56 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 659,500.00 |
| Sep 30, 2023 | 111,000.00 |